Anthera Pharmaceuticals Inc (ANTH)
0.00
USD |
OTCM |
May 06, 16:00
Anthera Pharmaceuticals Cash from Investing (Quarterly): 0.358M for March 31, 2018
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2018 | 0.358M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.186M |
| September 30, 2016 | -0.29M |
| June 30, 2016 | -0.662M |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -0.07M |
| March 31, 2015 | -0.01M |
| December 31, 2014 | 1.36M |
| September 30, 2014 | 0.54M |
| June 30, 2014 | 5.70M |
| March 31, 2014 | 2.40M |
| December 31, 2013 | 0.497M |
| September 30, 2013 | 0.644M |
| Date | Value |
|---|---|
| June 30, 2013 | -7.323M |
| March 31, 2013 | 1.495M |
| December 31, 2012 | -3.845M |
| September 30, 2012 | 0.841M |
| June 30, 2012 | -0.666M |
| March 31, 2012 | -0.113M |
| December 31, 2011 | 1.978M |
| September 30, 2011 | 0.249M |
| June 30, 2011 | 6.683M |
| March 31, 2011 | 11.32M |
| December 31, 2010 | -1.627M |
| September 30, 2010 | -6.429M |
| June 30, 2010 | -15.30M |
| March 31, 2010 | -0.0057M |
| December 31, 2009 | 0.0404M |
| September 30, 2009 | -0.0039M |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.381M |
| Cash from Financing (Quarterly) | 14.91M |